February 4, 2020
Nearly six months after receiving approval, Daiichi Sankyo Espha said on February 3 that it will list its authorized generic (AG) version of MSD/Bayer’s major hyperlipidemia drug Zetia (ezetimibe) in June and roll it out the same month. In Japan,...read more